Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
03/2005
03/15/2005US6867201 For therapy of abnormal cell growth, such as cancer, in mammals
03/15/2005US6867200 Anticancer agents; anticoagulants
03/15/2005US6867198 Agents and methods for the treatment of proliferative diseases
03/15/2005CA2246595C Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones
03/15/2005CA2146852C New substituted pyrazole derivatives, processes for their preparation and their use as herbicides
03/15/2005CA2086914C Quinolone-and naphthyridone-carboxylic acid derivatives
03/15/2005CA2063671C Aminoguanidines
03/11/2005WO2005103048A1 Quinolone carboxylic acid derivatives, thereof preparation and usage
03/10/2005WO2005021547A2 Heterocyclic cannabinoid cb2 receptor antagonists
03/10/2005WO2005021546A1 Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases
03/10/2005WO2005021545A1 IMIDAZO[1,5-a]PYRIDINE OR IMIDAZO[1,5-a]PIPERIDINE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF MEDICAMENT AGAINST 5-HT2A RECEPTOR-RELATED DISORDERS
03/10/2005WO2005021544A2 N3-substituted imidazopyridine-derivatives as c-kit inhibitors
03/10/2005WO2005021539A1 Benzimidazolone compounds having 5-ht4 receptor agonistic activity
03/10/2005WO2005021538A1 Novel chelating agents and chelates and their use
03/10/2005WO2005021536A2 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors
03/10/2005WO2005021533A1 Substituted isoquinoline derivatives and methods of use
03/10/2005WO2005021519A2 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases
03/10/2005WO2005021513A1 Novel condensed n-pyrazinyl-sulphonamides and their use in the treatment of chemokine mediated diseases
03/10/2005WO2005020999A1 Aryloxy and arylalkyleneoxy substituted imidazoquinolines
03/10/2005WO2005020987A1 Heterocyclic amide derivatives which posses glycogen phosphorylase inhibitory activity
03/10/2005WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/10/2005WO2005003065A3 Sulfonamide substituted imidazoquinolines
03/10/2005WO2004112793B1 Guanidino-substituted quinazolinone compounds as mc4-r agonists
03/10/2005WO2004087880A3 Compounds and their use to treat diabetes and related disorders
03/10/2005US20050054709 3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptideYreceptors ligands useful in the treatment of obesity and other disorders
03/10/2005US20050054701 Heterocyclic inhibitors of MEK and methods of use thereof
03/10/2005US20050054680 Agonists and antagonists of 5h3-like receptors of invertebrates as pesticides
03/10/2005US20050054678 Nitrogenous five-membered ring compounds
03/10/2005US20050054672 Quinolinone derivatives
03/10/2005US20050054669 Process for the synthesis of zolpidem
03/10/2005US20050054666 Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate
03/10/2005US20050054661 Irritable bowel disorders; anxiolytic agents; antidepressants
03/10/2005US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression
03/10/2005US20050054645 Aids therapy; side effect reduction
03/10/2005US20050054644 Hydrolytically-resistant boron-containing therapeutics and methods of use
03/10/2005US20050054640 1H-1-Amino-imidazo[4,5-c]quinoline derivatives as anticarcinogenic, antitumor, and viricidal agents
03/10/2005US20050054634 Azepinoindole derivatives as pharmaceutical agents
03/10/2005US20050054631 Substituted indoles as inhibitors of poly (ADP-ribose) polymerase (PARP)
03/10/2005US20050054629 Antiproliferative agents; anticancer agents; restenosis
03/10/2005DE10392346T5 Komplex aus cyclischem Amid und Übergangsmetall und Bleichkatalysator Complex of cyclic amide and transition-metal bleach catalyst and
03/10/2005CA2537364A1 Imidazo[1,5-a]pyridine or imidazo[1,5-a]piperidine derivatives and their use for the preparation of medicament against 5-ht2a receptor-related disorders
03/10/2005CA2537123A1 New compounds
03/10/2005CA2536783A1 Novel chelating agents and chelates and their use
03/10/2005CA2536174A1 N3-substituted imidazopyridine-derivatives as c-kit inhibitors
03/10/2005CA2535265A1 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/10/2005CA2533175A1 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases
03/10/2005CA2531506A1 Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases
03/09/2005EP1512686A1 Imidazonaphthyridines and their use in inducing cytokine biosythesis
03/09/2005EP1512685A1 Imidazonaphthyridines and their use in inducing cytokine biosythesis
03/09/2005EP1511749A1 Novel interleukin-1beta converting enzyme inhibitors
03/09/2005EP1511748A1 8-fluorimidazo(1,2-a)pyridine derivatives as ligands for gaba receptors
03/09/2005EP1511747A1 Imidazo-pyridine derivatives as ligands for gaba receptors
03/09/2005EP1511746A2 Process for imidazo[4,5-c]pyridin-4-amines
03/09/2005EP1511744A2 Bis-benzimidazoles and related compounds as potassium channel modulators
03/09/2005EP1511742A1 Kinase inhibitors
03/09/2005EP1511728A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
03/09/2005EP1511710A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer s disease, type 2 diabetes, and parkinson s disease
03/09/2005EP1451188B1 4-(oxadiazol-3-yl)-1,4-diazabicyclo 3.2.2]-nonane derivatives, preparation and therapeutic use thereof
03/09/2005EP1370549A4 Methods for the preparation of mirtazapine intermediates
03/09/2005EP1057814B1 Tetrahydrobenzindole derivatives
03/09/2005EP1018008B1 Method of identification of leads or active compounds
03/09/2005EP0817627B1 Protein kinase c inhibitors
03/09/2005CN1592747A Diazabicyclo alkane derivatives with NK1 antagonistic activity
03/09/2005CN1592743A Inhibitors of glycogen synthase kinase 3
03/09/2005CN1592621A Zolpidem hemitartrate
03/09/2005CN1590387A Preparation method of mehailuolin -1, 5- naphthaline disulfonate
03/09/2005CN1192029C Agents for improving learning or memory
03/09/2005CN1192018C Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds
03/09/2005CN1192009C Soluble chromophore containing solubilizing group easy to be removed
03/08/2005US6864265 Chemokine receptor binding heterocyclic compounds
03/08/2005US6864259 Antibacterial agents
03/08/2005US6864253 Heterocyclic amines such as 1-(3,4-methylenedioxyphenyl)-2-(5 -(3,4-dimethoxyphenyl)pyrimidin-2-yl)- 2,3,4,9-tetrahydro-1H-beta-carboline, used as enzyme inhibitors for prophylaxix of sexual disorders
03/08/2005US6863647 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
03/08/2005CA2134009C Bicyclic amidines, process for their preparation, and their use as catalyst
03/03/2005WO2005019216A1 Aminobenzimidazole derivatives
03/03/2005WO2005019215A1 [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
03/03/2005WO2005019192A1 Urea derivatives and their use as tyrosinkinase inhibitors
03/03/2005WO2005018638A1 Mitotic kinesin inhibitors
03/03/2005WO2005018567A2 Compounds and compositions for the treatment of diabetes and diabetes-related disorders
03/03/2005WO2005018556A2 Hydroxylamine substituted imidazo-containing compounds
03/03/2005WO2005018555A2 Lipid-modified immune response modifiers
03/03/2005WO2005018551A2 Oxime substituted imidazo-containing compounds
03/03/2005WO2005003098B1 Heterocyclically substituted pentanol derivatives, method for the production thereof, and use thereof as anti-inflammatory agents
03/03/2005WO2004104004A3 Triaza-spiro compounds as nociceptin analogues and uses thereof
03/03/2005WO2004104001A3 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase
03/03/2005WO2004101553B1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
03/03/2005WO2004087701A8 Cyclic benzimidazoles
03/03/2005WO2004086861A3 Fungicidal properties of sampangine and its analogs to agriculturally important fungal plant pathogens
03/03/2005WO2004001058A3 Transcription factor modulating compounds and methods of use thereof
03/03/2005US20050049424 6-Hydroxy isoflavones derivatives and medicaments involving same
03/03/2005US20050049419 Heterocyclic inhibitors of MEK and methods of use thereof
03/03/2005US20050049416 Preparing renzapride (hydrochloride) on a laboratory or industrial scale by a simplified process of forming the acyl chloride derivative of 2-(methoxy),3-acyamino,5-chlorobenzoic acid by reacting oxalyl or thionyl chloride in a solvent, e.g. dimethylformamide; coupling with 1-diazabicylo(3.3.1)nonane
03/03/2005US20050049290 Benzimidazole derivatives and their use as gnrh antagonists
03/03/2005US20050049277 Histamine H3 receptor antagonists; such as 2-(4-(n-ethyl)anilinoethoxyphenyl)imidazo[1,2-a]pyridine
03/03/2005US20050049276 Imidazopyridines and triazolopyridines
03/03/2005US20050049274 Selective, potent small molecule protein tyrosine kinase inhibitors; such as 6-chloro-3-(3-methyl-isoxazol-5-yl)-4-(pyridin-4-yl)-1H-quinolin-2-one
03/03/2005US20050049270 6H,11H-Indole-[3,2-C]-Isoquinoline-5-one derivatives; nuclear enzyme poly (ADP-ribose) synthetase inhibitors; inflammatory and/or reperfusion diseases
03/03/2005US20050049265 Use of inhibitors of i$g(k)b kinease for the treatment of cancer
03/03/2005US20050049260 2-phenyl-4-pyridinyl- or -pyrimidinyl derivatives, e.g., N-Cyclopentyl-3-[2-(cyclopentylamino)-4-pyrimidinyl]-2-(4-methoxyphenyl)-pyrazolo[1,5-a]pyridin-7-amine and; especially for treatment of herpes simplex virus 1 and 2
03/03/2005US20050049259 Viricides; for the prophylaxis and treatment of herpes viral infections
1 ... 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 ... 646